Naproxen
Back to searchMolecule Structure
Scientific Name
Naproxen
Description of the Drug
Naproxen is an NSAID used to treat rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, polyarticular juvenile idiopathic arthritis, tendinitis, bursitis, acute gout, primary dysmenorrhea, and mild to moderate pain.
http://www.drugbank.ca/drugs/DB00788
Brand Name(s)
Aleve, Anaprox, Arthrosin 250, Arthrosin 250 ec, Arthrosin 500, Arthrosin 500 ec, Condrotec, Ec-naprosyn, Equiproxen, Feminax ultra, Grenoxal, Kenosyn, Laraflex, Napratec op, Naprosyn, Naprosyn 375, Naprosyn ec, Naproxen, Nycopren, Pranoxen continus, Prosaid, Rheuflex 250, Rheuflex 500, Rimoxyn, Stirlescent, Timpron, Timpron 250 ec, Timpron 500 ec, Valrox, Vimovo
Company Owner(s)
Dava Pharmaceuticals Inc, Lnk International Inc, Invagen Pharmaceuticals Inc, Hamilton Pharmaceuticals Ltd, Watson Laboratories Inc, Yichang Humanwell Pharmaceutical Co Ltd, Mylan Pharmaceuticals Inc, Purepac Pharmaceutical Co, Pld Acquisitions Llc, Amneal Pharmaceuticals Llc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Cyclooxygenase | PROTEIN FAMILY | INHIBITOR | CHEMBL2094253 |
Clinical Trial(s)
Unichem Links
Atlas | naproxen | ||||||
SureChEMBL | SCHEMBL3046 | ||||||
Human Metabolome Database | HMDB0001923 | ||||||
DrugBank | DB00788 | ||||||
PubChem: Thomson Pharma | 15172374 | 15172373 | |||||
PubChem | 156391 | ||||||
Mcule | MCULE-2589082817 | MCULE-8718466451 | |||||
NMRShiftDB | 20209411 | ||||||
LINCS | LSM-5689 | ||||||
PDBe | NPS | ||||||
BindingDB | 50339185 | ||||||
EPA CompTox Dashboard | DTXSID4040686 | ||||||
DrugCentral | 1883 | ||||||
Brenda | 38412 | 69452 | 7679 | 174908 | |||
ChemicalBook | CB8422325 | CB8274937 | |||||
Guide to Pharmacology | 5230 | ||||||
rxnorm | VIMOVO | ANAPROX | NAPROXEN | NAPROXEN SODIUM | NAPROSYN | NAPRELAN | ALEVE |
ChEBI | 7476 | ||||||
ZINC | ZINC000000105216 |